tiprankstipranks
Trending News
More News >
Mangalam Organics Ltd (IN:MANORG)
:MANORG
India Market
Advertisement

Mangalam Organics Ltd (MANORG) AI Stock Analysis

Compare
0 Followers

Top Page

IN:MANORG

Mangalam Organics Ltd

(MANORG)

Select Model
Select Model
Select Model
Neutral 54 (OpenAI - 4o)
Rating:54Neutral
Price Target:
₹542.00
▲(1.92% Upside)
The overall stock score is primarily influenced by weak financial performance and bearish technical indicators. While the company shows revenue growth and operational improvements, profitability and cash flow issues are concerning. The technical analysis indicates negative market sentiment, and the valuation is fair but not compelling. The absence of earnings call and corporate events data limits additional insights.

Mangalam Organics Ltd (MANORG) vs. iShares MSCI India ETF (INDA)

Mangalam Organics Ltd Business Overview & Revenue Model

Company DescriptionMangalam Organics Ltd (MANORG) is a leading manufacturer in the chemical industry, primarily engaged in the production and distribution of terpene and resin-based products. The company operates in sectors including industrial chemicals, essential oils, and specialty chemicals, catering to a variety of industries such as paints, adhesives, rubber, and pharmaceuticals. With a focus on sustainability and innovation, Mangalam Organics Ltd has established itself as a key player in the organic chemicals market.
How the Company Makes MoneyMangalam Organics Ltd generates revenue through the manufacturing and sale of its core product lines, which include terpene and resin-based chemicals. These products are essential raw materials for various industrial applications, including the production of adhesives, coatings, and fragrances. The company earns money by supplying these chemicals to a diverse customer base across multiple industries. Additionally, Mangalam Organics may engage in strategic partnerships and contracts with other industrial players to enhance its market reach and distribution capabilities, further contributing to its revenue streams.

Mangalam Organics Ltd Financial Statement Overview

Summary
Mangalam Organics shows positive revenue growth and operational efficiency improvements, yet profitability and cash flow generation remain weak. The balance sheet reflects moderate leverage and stability, but the low return on equity and negative cash flow trends pose risks. Strategic focus on enhancing profitability and cash flow is essential to strengthen financial health.
Income Statement
65
Positive
Mangalam Organics exhibited a strong revenue growth of 7.39% from 2024 to 2025, with an improved gross profit margin of 48.40% in 2025, up from 22.89% in 2024. However, the net profit margin remains low at 2.38% due to increased expenses, limiting profitability. The EBIT and EBITDA margins also show improvement, indicating efficient operations despite the low net income.
Balance Sheet
58
Neutral
The company has a moderate debt-to-equity ratio of 0.93 in 2025, indicating a balanced use of debt and equity. The return on equity (ROE) is low at 4.29%, reflecting limited profitability relative to shareholder investment. The equity ratio is satisfactory at 47.02%, suggesting a stable financial structure but highlighting potential risks if profits do not improve.
Cash Flow
52
Neutral
Cash flow performance is concerning, with negative free cash flow growth of -329.40% from 2024 to 2025. Operating cash flow turned negative, indicating cash generation issues. The operating cash flow to net income ratio is negative, suggesting operational inefficiencies. These factors pose a risk to liquidity and future investment capability.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue5.30B5.30B4.94B4.93B4.91B3.38B
Gross Profit2.57B2.57B1.13B701.20M1.47B1.72B
EBITDA589.13M589.13M390.38M-24.27M924.25M1.28B
Net Income125.97M125.97M42.86M-272.25M537.43M847.79M
Balance Sheet
Total Assets6.24B6.24B4.85B5.06B5.60B3.11B
Cash, Cash Equivalents and Short-Term Investments189.27M189.27M20.19M12.79M12.78M343.55M
Total Debt2.72B2.72B1.73B1.90B2.12B243.11M
Total Liabilities3.30B3.30B2.05B2.30B2.56B596.26M
Stockholders Equity2.93B2.93B2.81B2.76B3.04B2.52B
Cash Flow
Free Cash Flow0.00-751.15M327.48M361.57M-1.84B-27.60M
Operating Cash Flow0.00-78.44M727.23M769.23M-841.04M262.79M
Investing Cash Flow0.00-670.47M-395.09M-407.80M-995.25M-281.47M
Financing Cash Flow0.00736.26M-325.52M-355.77M1.83B22.66M

Mangalam Organics Ltd Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price531.80
Price Trends
50DMA
536.77
Positive
100DMA
547.77
Negative
200DMA
479.84
Positive
Market Momentum
MACD
-1.11
Positive
RSI
41.34
Neutral
STOCH
13.90
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MANORG, the sentiment is Neutral. The current price of 531.8 is below the 20-day moving average (MA) of 563.21, below the 50-day MA of 536.77, and above the 200-day MA of 479.84, indicating a neutral trend. The MACD of -1.11 indicates Positive momentum. The RSI at 41.34 is Neutral, neither overbought nor oversold. The STOCH value of 13.90 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:MANORG.

Mangalam Organics Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
81
Outperform
6.15B5.5025.35%0.77%11.59%39.65%
63
Neutral
3.92B25.716.25%0.22%25.15%-16.43%
60
Neutral
6.73B79.545.10%2.99%45.22%
58
Neutral
1.14B-11.694.51%-16.39%-410.09%
54
Neutral
₹4.55B19.6711.14%309.69%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:MANORG
Mangalam Organics Ltd
531.80
11.25
2.16%
IN:AARTISURF
Aarti Surfactants Ltd.
464.00
-359.92
-43.68%
IN:ANDHRAPET
Andhra Petrochemicals Limited
52.33
-42.14
-44.61%
IN:INTLCONV
International Conveyors Ltd.
97.10
-1.55
-1.57%
IN:MAHASTEEL
Mahamaya Steel Industries Ltd.
409.60
208.00
103.17%
IN:MANGALAM
Mangalam Drugs & Organics Ltd.
72.07
-55.48
-43.50%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 27, 2025